Taxol, Paclitaxel

Taxol, Paclitaxel Newswire

Comprehensive Real-Time News Feed for Taxol, Paclitaxel (generic).

Results 1 - 20 of 25 in Taxol, Paclitaxel (generic)

  1. INSYS Therapeutics Receives FDA Orphan Drug Designation For Liposome...Read the original story

    Tuesday Dec 9 | BioSpace

    Insys Therapeutics, Inc. , a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to its Liposome Entrapped Paclitaxel Easy to Use candidate for the treatment of gastric cancer. LEP-ETU is an improved formulation of paclitaxel, a widely used chemotherapeutic agent.

    Comment?

  2. Insys Therapeutics Receives FDA Orphan Drug Designation for Liposome...Read the original story

    Tuesday Dec 9 | Market Wire

    LEP-ETU is an improved formulation of paclitaxel, a widely used chemotherapeutic agent. "We are pleased to have received orphan drug designation for LEP-ETU to treat gastric cancer, a devastating and difficult-to-treat disease," said Michael L. Babich, President and Chief Executive Officer.

    Comment?

  3. AbVitro Appoints Samuel Broder, M.D., to its Board of Directors and...Read the original story

    Nov 5, 2014 | Customer Interaction Solutions

    "We are very fortunate to have attracted such an experienced clinician scientist with both academic and industry experience to our board," said Jeffrey M. Ostrove, Ph.D., AbVitro's chief executive officer. "Dr. Broder brings a wealth of knowledge in the immuno-oncology and immunologic disease space, supporting many of the areas that our immune sequencing technology is so powerful in."

    Comment?

  4. AbVitro Inc. Appoints Samuel Broder, M.D. , To Its Board Of...Read the original story

    Nov 4, 2014 | BioSpace

    Dr. Broder, former director of the National Cancer Institute, brings extensive experience in oncology and drug development. "We are very fortunate to have attracted such an experienced clinician scientist with both academic and industry experience to our board," said , Ph.D., AbVitro's chief executive officer.

    Comment?

  5. Phyton Biotech Launches New WebsiteRead the original story

    Oct 7, 2014 | Freshnews

    Phyton Biotech, the pioneer in plant cell fermentation technology with the world's largest capacity for paclitaxel and docetaxel API via PCF, has launched a new website: www.phytonbiotech.com . The new website maintains Phyton's commitment to being the best commercial supplier of paclitaxel and docetaxel API in the world and also emphasizes Phyton's increased focus on Development Services for plant-derived actives via PCF and for complex small molecules.

    Comment?

  6. Disulfide Bond Helps Cancer Prodrugs Assemble Into NanoparticlesRead the original story w/Photo

    Sep 19, 2014 | Chemical & Engineering News

    Chemists have coaxed anticancer prodrugs to form easy-to-deliver nanoparticles by inserting a single disulfide bond into the molecules . The nanoparticles carry more drug molecules per weight than commercial forms of the medications.

    Comment?

  7. Findings on Lung Cancer Reported by Investigators at Shenyang...Read the original story

    Sep 4, 2014 | Hispanic Business

    Herein, we reported an active targeting strategy with peptide-mediated nanoparticles deep into tumor parenchyma, which iRGD conjugated D-a-tocopheryl polyethylene glycol 1000 succinate mediated codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance." The news reporters obtained a quote from the research from , "Pluronic P85-polyethyleneimine/TPGS complex nanoparticles incorporated with iRGD-TPGS conjugate codelivering PTX and shSur systems could induce effective cellular uptake, RNAi effects, and cytotoxicity on A549 and A549/T cells.

    Comment?

  8. Breast Cancer Chemotherapy Varies Widely: Study Raises Questions About Early Treatment ChoicesRead the original story w/Photo

    Aug 13, 2014 | Forbes.com

    Last month, the Journal of Clinical Oncology reported that six chemotherapy regimens commonly given to patients with early-stage breast cancer vary widely in their side effects.

    Comment?

  9. Patent Issued for Process for Preparing Taxoids from Baccatin Derivatives Using Lewis Acid CatalystRead the original story

    Aug 6, 2014 | Hispanic Business

    Editor at Biotech Week -- A patent by the inventors Kung, Liang-Rern ; Chang, Shih-Sheng ; Fang, Tung-Shen ; Lin, Shu-Fen ; Chang, Cheng-Chang ; Chen, Chia-Hui ; Hung, Yi-Ting .

    Comment?

  10. Researchers at University of North Carolina Describe Findings in...Read the original story

    Jul 30, 2014 | Hispanic Business

    A lipophilic paclitaxel derivative C22-PX was synthesized and incorporated into lipid-based NPs."

    Comment?

  11. New Paclitaxel Therapy Study Findings Have Been Reported by J.K. Lu...Read the original story

    Jul 30, 2014 | Hispanic Business

    But surprisingly, it was found in our study that PEG-PTX could form a novel nanoparticle system with free PTX."

    Comment?

  12. Recent Studies from Nanjing Medical University Add New Data to...Read the original story

    Jul 16, 2014 | Hispanic Business

    To solve the problem, surface-functionalized polymer nanoparticles are regarded as promising tumor-targeting delivery system."

    Comment?

  13. SLU researchers see possible answer to chemo pain in a multiple sclerosis drugRead the original story

    Jul 2, 2014 | Hispanic Business

    "The chemotherapy drug paclitaxel is widely used to treat many forms of cancer, including breast, ovarian and lung cancers," said Salvemini.

    Comment?

  14. Multiple sclerosis drug offers possible answer to chemo painRead the original story w/Photo

    Jun 25, 2014 | Medical News Today

    In a recently published study in the Journal of Biological Chemistry , Saint Louis University professor of pharmacological and physiological sciences Daniela Salvemini, Ph.D. describes two discoveries: a molecular pathway by which a painful chemotherapy side effect happens and a drug that may be able to stop it.

    Comment?

  15. Possible answer to chemo pain found in multiple sclerosis drugRead the original story w/Photo

    Jun 23, 2014 | Science Daily

    Two discoveries have been described by researchers: a molecular pathway by which a painful chemotherapy side effect happens and a drug that may be able to stop it.

    Comment?

  16. SLU researchers discover pain pathway and potential way to block itRead the original story w/Photo

    Jun 24, 2014 | Medical News

    "The chemotherapy drug paclitaxel is widely used to treat many forms of cancer , including breast, ovarian and lung cancers," said Salvemini.

    Comment?

  17. Chemotherapy likely to get less painfulRead the original story

    Jun 24, 2014 | Nerve News

    In a major breakthrough that has long term implications for cancer patients, researchers have discovered the pain pathway in chemotherapy and also a potential way to block it.

    Comment?

  18. Researchers see possible answer to chemo pain in a multiple sclerosis drugRead the original story

    Jun 23, 2014 | PhysOrg Weblog

    In a recently published study in the Journal of Biological Chemistry , Saint Louis University professor of pharmacological and physiological sciences Daniela Salvemini, Ph.D. describes two discoveries: a molecular pathway by which a painful chemotherapy side effect happens and a drug that may be able to stop it.

    Comment?

  19. SLU researchers see possible answer to chemo pain in a multiple sclerosis drugRead the original story

    Jun 22, 2014 | EurekAlert!

    In a recently published study in the Journal of Biological Chemistry , Saint Louis University professor of pharmacological and physiological sciences Daniela Salvemini, Ph.D. describes two discoveries: a molecular pathway by which a painful chemotherapy side effect happens and a drug that may be able to stop it.

    Comment?

  20. Tailoring treatment in ovarian cancerRead the original story w/Photo

    Jun 11, 2014 | PhysOrg Weblog

    The prognosis for ovarian cancer patients is poor with only 3 out of 10 women living at least 5 years after diagnosis.

    Comment?